


Men's Health
Daily optionPDE5 inhibitor with the longest active window on market. Daily low-dose removes the timing problem. Every intake cleared by a licensed provider.
Subscribe & Save
Easy to cancel anytime
$2/mo
One Time Purchase
Available after provider review
$3
Tadalafil is a long-acting PDE5 inhibitor with a plasma half-life of ~17.5 hours, producing a clinical window of 24-36 hours. RCT response rates sit at 70-80% for organic ED; daily low-dose (2.5-5 mg) is validated for both ED and BPH. Provider review clears cardiovascular status, nitrate use, alpha-blocker overlap, and hepatic function before dispensing.
DirectionsDaily dosing: take one tablet at the same time each day. On-demand: take 30-60 minutes before activity as directed by your provider. Do not exceed the prescribed daily amount.
Prescription products require clinical eligibility and provider approval.
Medication availability varies by state and clinical criteria.
Fit check
Using it well
Third-party tested where applicable. Every regulated Rx clears licensed provider review under state rules - no exceptions.
Most protocols perform better when the baseline is measured before you start. Add ApoB, HbA1c, fasting insulin, and the hormones that matter for your goal.
See lab packagesGenerative engine summary
Where we ship
Tadalafil is gated by state licensure and pharmacy access. Confirm eligibility in your state before you book the assessment.
Related Glossary
Questions
Daily is the quality-of-life choice - no clock, no food timing. On-demand works if intimacy is infrequent or side effects from daily dosing are an issue. Your provider confirms which fits.
Yes. TRT addresses low testosterone; tadalafil handles the vascular side. Many members run both when a lab workup points there. Coaching ties the two protocols together.
On-demand: one dose, same dose-response curve as trial data. Daily: most members are at steady-state by day 5. If nothing shifts by week 2, the conversation moves back to the provider for dose or diagnosis.
Multi-year RCT data is reassuring when eligibility is respected. Annual labs (lipids, LFTs, PSA if age-indicated) are part of the monitoring plan, not a bolt-on.